STAAR Surgical Predicts Significant Growth in Net Sales for FY24

Thursday, 4 April 2024, 11:26

STAAR Surgical anticipates a considerable increase in net sales for the fiscal year 2024. In Q1, the company recorded net sales surpassing $77 million, with U.S. ICL sales achieving $5 million. This positive outlook has resulted in a rise in the company's stock price.
LivaRava Finance Meta Image
STAAR Surgical Predicts Significant Growth in Net Sales for FY24

STAAR Surgical Forecasts Strong Net Sales

STAAR Surgical has announced its projected increase in net sales for the fiscal year 2024. This positive forecast is backed by the company's promising Q1 performance, with net sales exceeding $77 million. Notably, U.S. ICL sales have also shown significant growth, reaching $5 million.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe